Macquarie reduces forecasts as follows (it had previously been way above consensus):
FY22
EBITDA: $314m
NPAT: $176m
FY23
EBITDA: $324m
NPAT: $179m
Points out that on an EV/EBITDA multiple, SWM is trading at half the valuation of NEC, so opportunity for ongoing re-rate.
Believes that the biggest negative to the half-year results was the failure to pay a dividend, especially since Management had previously indicated that dividends would be suspended until refinancing of the debt facility, and this was completed in October 2021.
Now believes that it will embark on a $100m share buyback (would take debt/ebitda to 1.3x from the current 0.9x, and still be in the target band of 1.0 - 1.5x).
Lifts its valuation from 91c to 92c and rates Outperform.
- Forums
- ASX - By Stock
- Ann: Presentation of Half Year Results
SWM
seven west media limited
Add to My Watchlist
3.33%
!
15.5¢

Macquarie reduces forecasts as follows (it had previously been...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $238.5M |
Open | High | Low | Value | Volume |
14.5¢ | 15.5¢ | 14.5¢ | $141.7K | 946.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 1047806 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 0.150 |
6 | 1219305 | 0.145 |
15 | 1021259 | 0.140 |
10 | 190360 | 0.135 |
10 | 343803 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 999419 | 19 |
0.160 | 136037 | 7 |
0.165 | 638470 | 7 |
0.170 | 174770 | 10 |
0.175 | 496403 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SWM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online